AgencyIQ (@AgencyIQ) header
AgencyIQ (@AgencyIQ) profile picture

AgencyIQ

@AgencyIQ

Regulatory intelligence, simplified. Discover a new way to explore the people, policy, and processes shaping the modern #FDA regulatory environment.

 Washington, DC
agencyiq.com/
Joined January 2020
  • Tweets757
  • Following30
  • Followers552
571Media
Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)Photo by AgencyIQ (@AgencyIQ)
Seven years after its inception, the FDA has finalized its first guidance on the Voluntary Malfunction Summary Report (VMSR) program for medical devices. Read our analysis here: bit.ly/4gfmB7g #AgencyIQ #Politico #LifeSciences #FDA #Regulation #MedicalDevices
Graphic image with text announcing FDA finalizes guidance allowing certain device makers to submit quarterly malfunction reports. The source is AgencyIQ and the author is Laura DiAngelo, MPH.

ALT Graphic image with text announcing FDA finalizes guidance allowing certain device makers to submit quarterly malfunction reports. The source is AgencyIQ and the author is Laura DiAngelo, MPH.

566
Courtney Lias has been Acting Director of CDRH’s in vitro diagnostics office, known as OHT7, since the departure of Tim Stenzel at the end of 2023. Recently she confirmed she is now the permanent Director. Read our analysis: bit.ly/3yZwGnP #AgencyIQ #Politico #FDA
Image from AgencyIQ (@AgencyIQ)
316
ECHA has issued a new guide for NEAs, clarifying the tiered approach to mixtures classification under the CLP Regulation and strategies for reviewing duty holders’ classifications of hazardous mixtures. Read more: bit.ly/47lmz9T #AgencyIQ #Politico #Chemicals #ECHA
Image from AgencyIQ (@AgencyIQ)
176
Over a year since its initial draft guidance document on the use of PCCPs for medical devices that leverage machine learning, the agency has issued a new draft guidance on the use of PCCPs for all medical devices. Read more: bit.ly/3T12K1h #AgencyIQ #Politico #CDRH
Image from AgencyIQ (@AgencyIQ)
144
Don't miss out! Register here: bit.ly/4dhsJd2 to join us on tomorrow, Tuesday, August 27, at 12pm ET, for a free and informative webinar where AgencyIQ’s research team will discuss the what the FDA still has on its plate in 2024. #AgencyIQ #Politico #FDA #Webinar
Image from AgencyIQ (@AgencyIQ)
109
On August 9, Lykos Therapeutics received a CRL from the FDA, stating the agency will not currently approve its application for MDMA to treat post-traumatic stress disorder. AgencyIQ unpacks the announcement here: bit.ly/3WS4KKB #AgencyIQ #Politico #LifeSciences #FDA
Image from AgencyIQ (@AgencyIQ)
92
That’s a wrap on the #DNC2024! POLITICO kicked off the convention with an exclusive event for @POLITICOPro, @EENewsUpdates, and @AgencyIQ subscribers. Throughout the week, our reporting team hosted VIP Convention Conversations with some of the nation’s most influential Democrats
Image from AgencyIQ (@AgencyIQ)
Image from AgencyIQ (@AgencyIQ)
Image from AgencyIQ (@AgencyIQ)
Image from AgencyIQ (@AgencyIQ)
63
The AgencyIQ team is excited to attend RAPS Convergence this September! Be sure to visit us at booth 708. Learn more about the event and access exclusive AgencyIQ content here: bit.ly/4fYXipU #AgencyIQ #Politico #Regulation #RAPS
Promotional image for the RAPS 2024 Convergence event which will be attended by AgencyIQ by POLITICO. The event is scheduled for September 17-19 in Long Beach, and the booth number is 708. The image features a background image of palm trees with a purple overlay.

ALT Promotional image for the RAPS 2024 Convergence event which will be attended by AgencyIQ by POLITICO. The event is scheduled for September 17-19 in Long Beach, and the booth number is 708. The image features a background image of palm trees with a purple overlay.

58
The FDA has finalized its guidance on dose optimization for oncology products. AgencyIQ has combed through the final guidance document to tease out what’s new and what’s the same, read here: bit.ly/3WN0MTi #AgencyIQ #Politico #LifeSciences #Regulation #FDA #Oncology
Image from AgencyIQ (@AgencyIQ)
57
Earlier this year, the EMA hosted a multi-stakeholder workshop to discuss regulatory issues surrounding drug development of psychedelic products. Read the details here: bit.ly/3Ag97r6 #AgencyIQ #Politico #LifeSciences #Regulation #Regulatory #EMA
Image from AgencyIQ (@AgencyIQ)
48
In its inaugural meeting, FDA’s Genetic Metabolic Diseases Advisory Committee heard Zevra’s second try for arimoclomol to treat ultra-rare lysosomal storage disorder Niemann-Pick Type C. Read the details here: bit.ly/3X2bmHI #AgencyIQ #Politico #Regulation #FDA
Image from AgencyIQ (@AgencyIQ)
1
72
The European Commission plans to implement exemptions introduced under the Stockholm Convention’s 2023 ban of UV-328, an ultraviolet-light absorbing persistent organic pollutant (POP). Read the details here: bit.ly/4cqt6AX #AgencyIQ #Politico #Chemicals #Regulation #EU
Image from AgencyIQ (@AgencyIQ)
42
Register here: bit.ly/4dhsJd2 to join us on Tuesday, August 27, at 12pm ET, for a free and informative webinar where AgencyIQ’s research team will discuss the what the FDA still has on its plate in 2024. #AgencyIQ #Politico #FDA #Webinar
Image from AgencyIQ (@AgencyIQ)
50
Last month, the FDA published a new draft guidance document on diversity action plans. AgencyIQ answers some of the most common questions we’ve received about the guidance – and raise a few of our own. Read here: bit.ly/4dBmH6O #AgencyIQ #Politico #LifeSciences #FDA
Image from AgencyIQ (@AgencyIQ)
54
In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the months ahead. Read more: bit.ly/3X0aHGJ #AgencyIQ #Politico #Regulation #EuropeanMedicine #MedicalDevice
Image from AgencyIQ (@AgencyIQ)
36
Get the details on digital health updates, including: the Department of Health and Human Services’ new AI Office, FDA’s report on AI in surveillance, and coming policy. Read here: bit.ly/46Jzhim #AgencyIQ #Politico #LifeSciences #Regulation #FDA #HHS #NIST #AI
Image from AgencyIQ (@AgencyIQ)
59
This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead. Read here: bit.ly/3ytRDXO #AgencyIQ #Politico #Chemicals #Regulation #Regulatory #EU
Image from AgencyIQ (@AgencyIQ)
25
In this monthly resource, AgencyIQ looks at public data to determine what the FDA is likely to do in August and September. Read here: bit.ly/3LUh87E #AgencyIQ #Politico #LifeSciences #Regulation #Regulatory #FDA
This image features a promotional graphic from Politico's AgencyIQ, with a heading that reads "What We Expect the FDA to do in August and September 2024" by Alexander Gaffney, MS, RAC, set against a purple background.

ALT This image features a promotional graphic from Politico's AgencyIQ, with a heading that reads "What We Expect the FDA to do in August and September 2024" by Alexander Gaffney, MS, RAC, set against a purple background.

38
The recently available May 2024 meetings of the Medical Device Coordination Group provide insight into the European Commission’s efforts to fully implement the European medical device and diagnostic regulations. Read more: bit.ly/4fqBy5G #AgencyIQ #Politico #IVDR
Graphic by AgencyIQ from POLITICO featuring an article titled 'Top IVDR Notified Body concern: Lack of E.U. reference laboratories for high-risk diagnostics' by Corey Jaseph, MS, RAC.

ALT Graphic by AgencyIQ from POLITICO featuring an article titled 'Top IVDR Notified Body concern: Lack of E.U. reference laboratories for high-risk diagnostics' by Corey Jaseph, MS, RAC.

32
FDA has fulfilled its commitment under the Over-the-Counter Monograph Drug User Fee (OMUFA) program to issue final guidance on how sponsors can electronically submit monographs and other documents. Read more: bit.ly/4fp0jzb #AgencyIQ #Politico #FDA #OMUFA #OTC
An informational graphic with a deep purple background and white text stating "FDA finalizes guidance on electronic submissions for OTC products," written by Amanda Conti from AgencyIQ by POLITICO.

ALT An informational graphic with a deep purple background and white text stating "FDA finalizes guidance on electronic submissions for OTC products," written by Amanda Conti from AgencyIQ by POLITICO.

44
Load more